IRADIMED CORP - Common Stock (IRMD)

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Number of holders
32
Total 13F shares, excl. options
1,500,984
Shares change
-294,031
Total reported value, excl. options
$12,902,009
Value change
-$2,639,238
Number of buys
16
Number of sells
-29
Price
$8.59

Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2017

48 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q2 2017.
IRADIMED CORP - Common Stock (IRMD) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,500,984 shares of 12,733,410 outstanding shares and own 11.79% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (343,620 shares), Mondrian Investment Partners LTD (206,547 shares), VANGUARD GROUP INC (180,681 shares), AQR CAPITAL MANAGEMENT LLC (146,581 shares), Granite Investment Partners, LLC (112,262 shares), MENTA CAPITAL LLC (70,476 shares), Spark Investment Management LLC (66,900 shares), OxFORD Asset Management LLP (51,318 shares), BlackRock Inc. (42,749 shares), and FEDERATED INVESTORS INC /PA/ (40,400 shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.